In the STEP 4 trial, people who stopped semaglutide and switched to a placebo regained about 7% of their body weight over the following year, while those who kept taking it continued to lose weight
2016;39(Suppl 2):S205S209
Some researchers speculate that the additional GIP receptor activation may provide extra neuroprotective benefits
Masking Underlying Conditions: Sometimes, a medication itself isnt the direct issue, but the underlying medical condition it treats could be a reason for deferral
Maggie was placed on a temporary low-salicylate and oxalate diet, reducing oxalates by 510%
Good use cases include tendon irritation, ligament sprains, muscle strains, plantar fascia irritation, rotator cuff irritation, Achilles tendinopathy, patellar tendinopathy, tennis elbow, golfers elbow, and joint-adjacent soft-tissue pain